MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment

MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment
Conditions:   Cancer;   Solid Tumor;   Non Small Cell Lung Cancer;   Colorectal Cancer;   Bladder Cancer
Intervention:   Diagnostic Test: Personalized Cancer Monitoring (PCM)
Sponsor:   Invitae Corporation
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

February 3, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments